The Global Pregabalin API Market was valued at USD 415.6 Million in 2023 and is projected to reach USD 528.9 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period (2023–2028). This growth is being driven by the rising prevalence of neuropathic pain and epilepsy disorders, expanding generic drug manufacturing, and the increasing adoption of cost-effective API solutions across both developed and emerging pharmaceutical markets.

As the pharmaceutical industry evolves towards more cost-effective and high-quality active pharmaceutical ingredients, the focus is on the key manufacturers who are driving production scalability, regulatory compliance, and innovation in synthesis processes. In this blog, we profile the Top 10 Companies in the Pregabalin API Industry, a mix of established chemical giants and specialized API producers shaping the future of neurological drug manufacturing.

---

🔟 1. Teva Pharmaceutical Industries Ltd.

Headquarters: Tel Aviv, Israel
Key Offering: Pregabalin API (Purity ≥99.5%), Custom Synthesis Services

Teva is a global leader in generic pharmaceuticals and active pharmaceutical ingredients, with a robust portfolio that includes high-purity Pregabalin. The company operates state-of-the-art manufacturing facilities compliant with global regulatory standards, supplying bulk APIs to pharmaceutical companies worldwide.

Manufacturing Capabilities:

• Vertically integrated API and finished dosage form production

• Strategic focus on cost optimization and supply chain resilience

• Extensive R&D in process chemistry for enhanced yield and purity

Download FREE Sample Report:
2023-2028 Global and Regional Pregabalin API Industry Status and Prospects Professional Market – View in Detailed Research Report

---

9️⃣ 2. Sunshine Pharmaceutical Co., Ltd.

Headquarters: Shijiazhuang, Hebei, China
Key Offering: Pregabalin API (Purity ≥99%), Generic Drug Formulations

Sunshine Pharmaceutical is one of China’s major producers of Pregabalin API, serving both domestic and international markets. The company has invested significantly in GMP-compliant production lines and quality control systems.

Manufacturing Capabilities:

• Large-scale manufacturing capacity with competitive pricing advantages

• Strong focus on export markets including Europe, Asia, and Latin America

---

8️⃣ 3. Cadila Pharmaceuticals Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Pregabalin API (Purity ≥99.5%), Contract Manufacturing

Cadila’s API division has established itself as a reliable supplier of Pregabalin, leveraging India’s strong chemical manufacturing infrastructure and skilled workforce.

Manufacturing Capabilities:

• Advanced synthesis technology for high-purity Pregabalin production

• Focus on regulatory compliance with filings in over 50 countries

---

7️⃣ 4. SUANFARMA

Headquarters: Milan, Italy
Key Offering: High-Purity Pregabalin API, Custom Manufacturing Solutions

SUANFARMA specializes in the development and production of advanced pharmaceutical intermediates and APIs, including Pregabalin, for the global market.

Manufacturing Capabilities:

• European GMP and FDA-compliant manufacturing facilities

• Strong technical expertise in complex organic synthesis and process optimization

Download FREE Sample Report:
2023-2028 Global and Regional Pregabalin API Industry Status and Prospects Professional Market – View in Detailed Research Report

---

6️⃣ 5. Atom Pharma

Headquarters: Mumbai, Maharashtra, India
Key Offering: Pregabalin API (Purity ≥99%), Generic Bulk APIs

Atom Pharma has built a strong reputation as a reliable supplier of Pregabalin API, focusing on quality consistency and supply reliability for global pharmaceutical customers.

Manufacturing Capabilities:

• Specialization in neurological and psychiatric APIs with comprehensive quality systems

• Strategic partnerships with formulation manufacturers across key therapeutic segments

---

5️⃣ 6. VASUDHA PHARMA

Headquarters: Hyderabad, Telangana, India
Key Offering: Pregabalin API (Purity ≥99.5%), Research Grade Materials

VASUDHA PHARMA has emerged as a significant player in the Pregabalin API market, with manufacturing capabilities designed to meet both regulatory requirements and commercial-scale production needs.

Manufacturing Capabilities:

• Focus on developing efficient and environmentally sustainable manufacturing processes

• Expansion into regulated markets with DMF filings and customer-specific qualifications

---

4️⃣ 7. Kopran Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Pregabalin API (Purity ≥99.5%), Pharmaceutical Intermediates

Kopran manufactures Pregabalin API for various dosage forms, maintaining strict quality control throughout the manufacturing process.

Manufacturing Capabilities:

• Multiple manufacturing sites with dedicated API production facilities

• Emphasis on R&D for process improvement and cost-effective manufacturing methods

---

3️⃣ 8. Hanmi Fine Chemical Co., Ltd.

Headquarters: Seoul, South Korea
Key Offering: Pregabalin API (Purity ≥99%), Custom Synthesis

Hanmi Fine Chemical leverages South Korea’s advanced chemical industry infrastructure to produce high-quality Pregabalin API for global pharmaceutical companies.

Manufacturing Capabilities:

• Advanced manufacturing technologies for consistent API quality and purity

• Strategic focus on the Asian pharmaceutical market with expanding global presence

---

2️⃣ 9. Hubei Vanz Pharm Inc.

Headquarters: Wuhan, Hubei, China
Key Offering: Pregabalin API (Purity ≥99.5%), Generic Drug API Supply

Hubei Vanz Pharm has established manufacturing capabilities for Pregabalin API, focusing on meeting the increasing demand from generic drug manufacturers.

Manufacturing Capabilities:

• Export-oriented business model with significant market share in emerging economies

• Investment in modern production facilities and quality management systems

---

1️⃣ 10. Menovo Pharmaceutical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pregabalin API (Purity ≥99.5%), Contract API Manufacturing

Menovo Pharmaceutical has developed specialized expertise in Pregabalin API manufacturing, with capabilities spanning from laboratory-scale development to commercial production.

Manufacturing Capabilities:

• Strong emphasis on regulatory compliance and international quality standards

• Growing portfolio of regulatory submissions and customer approvals across multiple regions

Get Full Report Here:
2023-2028 Global and Regional Pregabalin API Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Pregabalin API Manufacturing is Smarter and More Efficient

The Pregabalin API market is undergoing significant transformation. While traditional manufacturing methods continue to dominate, the industry is investing heavily in continuous flow chemistry, green synthesis processes, and advanced purification technologies.

📈 Key Trends Shaping the Market:

• Accelerating adoption of Quality by Design (QbD) principles in API manufacturing

• Stringent regulatory requirements driving investments in quality systems and compliance infrastructure

• Growing demand for high-purity APIs from generic drug manufacturers seeking regulatory approvals

• Expansion of API production capacity in Asia to meet growing global demand for cost-effective neurological treatments.

Get Full Report Here:
2023-2028 Global and Regional Pregabalin API Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies listed above are not only supplying critical pharmaceutical ingredients, they’re advancing the manufacturing excellence of essential neurological medications.